In this case, which was decided on August 1, 2003, the Federal Circuit again addressed the question of anticipation by virtue of what was inherent in the prior...

This case saw a return to the question of what is meant by 35 USC 112 paragraph 6 which has been troubling the Federal Circuit and practitioners for much of the past...

In re Peterson involved an appeal from the USPTO Board of Appeals with respect to the patentability of the claims of a pending US patent...

This is a complex case involving a non-naturally occurring erythropoietin-glycoprotein product having a defined in vivo biological activity and having glycosylation which differs from that of human urinary...

This was a Paragraph IV certification case filed after Novopharm filed an ANDA to market a generic form of fenofibrate prior to expiration of the relevant...

The invention related to the isolation of the virus that caused “Mystery swine disease” (a.k.a Porcine Reproductive Respiratory Syndrome – PRRS). The claim was directed to growing and isolating a particular virus. The alleged infringement...